Michael Hauptmann

Professor and Head

Medizinische Hochschule Brandenburg Theodor Fontane

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Isabelle Thierry-Chef

Head of Medical Radiation Group

Barcelona Institute for Global Health

SPAIN

View details

David R Baldwin

University of Nottingham

UNITED KINGDOM

View details

Cécile M. Ronckers

Head / Sr Researcher

Universitätsmedizin der Johannes Gutenberg-Universität Mainz

GERMANY

View details

Bernd Förstner

University of Potsdam

GERMANY

View details

Cecile Janus

Erasmus University Rotterdam

NETHERLANDS

View details

Valérie Durieux

Université libre de Bruxelles

BELGIUM

View details

Colin Muirhead

Lecturer in Medical Statistics

Newcastle University

UNITED KINGDOM

View details

Corinne Faivre-Finn

The University of Manchester

UNITED KINGDOM

View details

Joanna Chorostowska-Wynimko

Head/Professor

Instytut Gruzlicy i Chorob Pluc

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michael Hauptmann

Research Interests

Explore related searches

Contact this professor

Articles (20)

A Historical Survey of Key Epidemiological Studies of Ionizing Radiation Exposure.

Patients with Stage IV Colorectal Carcinoma Selected for Palliative Primary Tumor Resection and Systemic Therapy Survive Longer Compared with Systemic Therapy Alone - A Retrospective Comparative Cohort Study.

Cox Proportional Hazards Regression in Small Studies of Predictive Biomarkers

Prognostic Value of Histopathologic Traits Independent of Stromal Tumor-Infiltrating Lymphocyte Levels in Chemotherapy-Naïve Patients with Triple-Negative Breast Cancer.

Finite-Sample Bias of the Linear Excess Relative Risk in Cohort Studies of Computed Tomography-Related Radiation Exposure and Cancer.

Protecting Mass-Gathering Events in a Pandemic with Testing Tracks and Transparent Information: An Experimental Study with Festival Guests.

Long-Term Outcomes of Young, Node-Negative, Chemotherapy-Naïve, Triple-Negative Breast Cancer Patients according to BRCA1 Status.

European Respiratory Society guideline on various aspects of quality in lung cancer care

A scoping review of statistical methods in studies of biomarker-related treatment heterogeneity for breast cancer.

De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP Trial.

Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults

The Cumulative Burden of Self-Reported, Clinically Relevant Outcomes in Long-Term Childhood Cancer Survivors and Implications for Survivorship Care: A DCCSS LATER Study.

External Validation and Clinical Utility Assessment of PREDICT Breast Cancer Prognostic Model in Young, Systemic Treatment-Naïve Women with Node-Negative Breast Cancer.

Versorgungsnahe Daten für Versorgungsanalysen – Teil 3 des Manuals

Brain cancer after radiation exposure from CT examinations of children and young adults: results from the EPI-CT cohort study.

A theory of change of an innovation for therapeutic care and meaningful living in a German nursing home.

PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients.

Axillary Staging after Neoadjuvant Chemotherapy for Initially Node-Positive Breast Carcinoma in Germany: Initial Data from the AXSANA study.

Radiotherapy-Related Dose and Irradiated Volume Effects on Breast Cancer Risk Among Hodgkin Lymphoma Survivors.

Development and Validation of Risk Prediction Models for Coronary Heart Disease and Heart Failure After Treatment for Hodgkin Lymphoma.

Collaborators (9)

Isabelle Thierry-Chef

David R Baldwin

Cécile M. Ronckers

Bernd Förstner

Cecile Janus

Valérie Durieux

Colin Muirhead

Corinne Faivre-Finn

Joanna Chorostowska-Wynimko

Make your next move.